Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis
Abstract Background Different clinical trials showed the superior efficacy of rupatadine compared to placebo at improving seasonal allergic rhinitis (SAR) symptoms, but no study has assessed if the response promoted is clinically meaningful. Methods This study is a pooled analysis of data of seven r...
Main Authors: | Joaquim Mullol, Iñaki Izquierdo, Kimihiro Okubo, Giorgio Walter Canonica, Jean Bousquet, Antonio Valero |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-10-01
|
Series: | Clinical and Translational Allergy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13601-019-0293-4 |
Similar Items
-
Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis
by: Antonio Valero, et al.
Published: (2020-04-01) -
Rupatadine oral solution for 2–5-year-old children with allergic rhinitis: a safety, open-label, prospective study
by: Santamaría E, et al.
Published: (2018-09-01) -
Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis
by: Erkan Yildiz, et al.
Published: (2019-12-01) -
Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications
by: Rosa M. Muñoz-Cano, et al.
Published: (2019-08-01) -
Symptoms of Allergic Rhinitis in Women during Early Pregnancy Are Associated with Higher Prevalence of Allergic Rhinitis in Their Offspring
by: Miwa Shinohara, et al.
Published: (2007-01-01)